BioSpace News Archive

Business

Exact Sciences to Report $265.5-266.5 Million in Revenue, 168 Percent Growth for 2017

For the full-year 2017, the company anticipates reporting revenue between $265.5 million and $266.5 million.

January 7, 2018
·
6 min read
Business

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene for Fully Human Monoclonal Antibody Drug Discovery

Harbour Biomed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human therapeutic monoclonal antibodies to BeiGene

January 7, 2018
·
2 min read
Business

Vanda Pharma Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and 2018 Guidance

Vanda Pharma today announced preliminary unaudited financial results for the fourth quarter and full year 2017 and its financial guidance for 2018.

January 7, 2018
·
7 min read
Business

ReWalk Robotics Appoints Ori Gon as CFO

The current CFO is leaving to pursue an outside opportunity after putting in place and executing on ReWalk’s business strategies in collaboration with the Company’s board and management team.

January 7, 2018
·
5 min read
Drug Development

Akcea Initiates Phase IIb Study of AKCEA-APOCIII-LRx in Patients With Hypertriglyceridemia and Established Cardiovascular Disease

The study will evaluate the safety and efficacy of different doses and dosing frequencies of AKCEA-APOCIII-LRx in this patient population and provide valuable information for a potential Phase 3 cardiovascular outcomes study.

January 7, 2018
·
7 min read
Business

Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones

Neurocrine Biosciences today announced an update on its business performance, including preliminary sales results for 2017 and key program initiatives for 2018.

January 7, 2018
·
8 min read
Business

MiMedx Releases Preliminary 2017 Revenue of $324.5M Representing a 32% Increase Over 2016

MiMedx today announced preliminary record revenue results for the fourth quarter and full-year 2017 and revenue expectations for the first quarter of 2018.

January 7, 2018
·
7 min read
Drug Development

Zymeworks Highlights Key 2017 Accomplishments and Announces 2018 Priorities

Zymeworks today provided key accomplishments from the past year and announced priorities for 2018.

January 7, 2018
·
6 min read
Drug Development

Semnur Pharma Begins Pivotal Phase III Trial For SP-102 in Patients With Lumbar Radicular Pain/Sciatica

In addition, the FDA has granted SP-102 Fast Track Designation for the treatment of lumbar radicular pain/sciatica.

January 7, 2018
·
6 min read
L’Oreal Advances its Commitment to Promoting Sun Safety With La Roche-Posay UV Sense, The First Battery-Free Wearable Electronic UV Sensor

L’Oreal furthered its 80-year commitment to sun safety with the unveiling of two technology products at the 2018 Consumer Electronics Show.

January 7, 2018
·
7 min read